Organisation paid for research Program year 2025 Source: CMS Open Payments

Unison Integrated Medicine

Neither a doctor nor a teaching hospital

Research payments

$307,030

5 payments

Through program year 2025, Unison Integrated Medicine is reported as receiving $307,030 in research payments, across 5 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2025	Research	$61	1
2024	Research	$32,453	1
2023	Research	$3,113	1
2022	Research	$200,773	1
2021	Research	$70,630	1

Breakdown

Who paid Research payments · program years 2021–2025

Amgen Inc. $271,403 2 payments
E.R. Squibb & Sons, L.L.C. $35,627 3 payments

Studies the money was for Research payments · program years 2021–2025

P3 switching study PK; plaque psoriasis $200,773 1 payment
ABP 654 P3 PsO Study $70,630 1 payment
Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis (POETYK PSO-LTE) $32,453 1 payment
Phase III Long Term Roll Over Psoriasis $3,113 1 payment
A Phase 3b/4 Multi-center, Randomized, Open-label, Long-term Safety Study of Deucravacitinib in Comparison to Ustekinumab in Participants with Moderate-to-Severe Plaque Psoriasis (PragmaTYK) $61 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.